Biogen Historical Balance Sheet
BIIB Stock | USD 225.21 2.48 1.09% |
Trend analysis of Biogen Inc balance sheet accounts such as Short Long Term Debt Total of 7.7 B, Other Current Liabilities of 969.8 M or Total Current Liabilities of 3.6 B provides information on Biogen's total assets, liabilities, and equity, which is the actual value of Biogen Inc to its prevalent stockholders. By breaking down trends over time using Biogen balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Biogen Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Biogen Inc is a good buy for the upcoming year.
Biogen Inventory |
|
Biogen |
About Biogen Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Biogen Inc at a specified time, usually calculated after every quarter, six months, or one year. Biogen Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Biogen and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Biogen currently owns. An asset can also be divided into two categories, current and non-current.
Biogen Balance Sheet Chart
Biogen Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Biogen Inc uses and utilizes its capital. It also shows what exactly a company owns and owes.
At present, Biogen's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Short and Long Term Debt Total is expected to grow to about 7.7 B, whereas Cash is forecasted to decline to about 723.1 M. Add Fundamental
Total Assets
Total assets refers to the total amount of Biogen assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Biogen Inc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Biogen balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Biogen Inc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Property Plant And Equipment Net
The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.Most accounts from Biogen's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Biogen Inc current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. At present, Biogen's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Short and Long Term Debt Total is expected to grow to about 7.7 B, whereas Cash is forecasted to decline to about 723.1 M.
2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 7.6B | 6.6B | 7.3B | 7.7B | Total Assets | 23.9B | 24.6B | 26.8B | 28.2B |
Biogen balance sheet Correlations
Click cells to compare fundamentals
Biogen Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Biogen balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 27.2B | 24.6B | 23.9B | 24.6B | 26.8B | 28.2B | |
Short Long Term Debt Total | 6.4B | 7.8B | 7.6B | 6.6B | 7.3B | 7.7B | |
Other Current Liab | 3.4B | 3.3B | 3.3B | 2.8B | 838.4M | 969.8M | |
Total Current Liabilities | 4.9B | 3.7B | 4.3B | 3.3B | 3.4B | 3.6B | |
Total Stockholder Equity | 13.3B | 10.7B | 11.0B | 13.4B | 14.8B | 15.5B | |
Property Plant And Equipment Net | 3.7B | 3.8B | 3.8B | 3.7B | 3.7B | 3.9B | |
Net Debt | 3.5B | 6.5B | 5.3B | 3.2B | 6.3B | 6.6B | |
Retained Earnings | 16.5B | 14.0B | 13.9B | 16.5B | 17.6B | 18.5B | |
Cash | 2.9B | 1.3B | 2.3B | 3.4B | 1.0B | 723.1M | |
Non Current Assets Total | 18.9B | 17.7B | 16.0B | 14.8B | 20.0B | 21.0B | |
Non Currrent Assets Other | (3.2B) | (1.4B) | 1.9B | 1.5B | 284.3M | 270.1M | |
Cash And Short Term Investments | 4.5B | 2.6B | 3.8B | 4.9B | 1.0B | 1.5B | |
Net Receivables | 1.9B | 1.9B | 1.5B | 2.1B | 2.1B | 2.2B | |
Common Stock Shares Outstanding | 187.4M | 161.3M | 149.6M | 146M | 145.6M | 283.0M | |
Liabilities And Stockholders Equity | 27.2B | 24.6B | 23.9B | 24.6B | 26.8B | 28.2B | |
Non Current Liabilities Total | 9.0B | 10.2B | 8.6B | 7.9B | 8.6B | 9.0B | |
Other Current Assets | 1.2B | 1.3B | 1.2B | 1.4B | 1.2B | 1.2B | |
Other Stockholder Equity | (3.0B) | (3.0B) | (2.8B) | (2.9B) | (2.7B) | (2.5B) | |
Total Liab | 13.9B | 13.9B | 12.9B | 11.2B | 12.0B | 12.6B | |
Property Plant And Equipment Gross | 3.7B | 3.8B | 3.8B | 3.7B | 6.1B | 6.4B | |
Total Current Assets | 8.4B | 6.9B | 7.9B | 9.8B | 6.9B | 7.2B | |
Accumulated Other Comprehensive Income | (135.2M) | (299M) | (106.7M) | (164.9M) | (153.7M) | (146.0M) | |
Intangible Assets | 3.5B | 3.1B | 2.2B | 1.9B | 8.4B | 8.8B | |
Accounts Payable | 530.8M | 454.9M | 589.2M | 491.5M | 403.3M | 423.5M | |
Short Term Investments | 2.3B | 1.6B | 1.3B | 1.5B | 1.5B | 0.0 | |
Inventory | 804.2M | 1.1B | 1.4B | 1.3B | 2.5B | 2.7B | |
Other Liab | 4.2B | 2.4B | 2.0B | 1.3B | 1.5B | 969.6M | |
Other Assets | 3.2B | 4.2B | 3.4B | 1.7B | 1.9B | 2.0B | |
Long Term Debt | 4.5B | 7.4B | 6.3B | 6.3B | 6.8B | 7.1B | |
Property Plant Equipment | 3.2B | 3.4B | 3.4B | 3.3B | 3.8B | 2.1B | |
Good Will | 5.8B | 5.8B | 5.8B | 5.7B | 6.2B | 3.2B | |
Net Tangible Assets | 4.1B | 1.9B | 2.9B | 5.8B | 6.7B | 4.1B | |
Noncontrolling Interest In Consolidated Entity | (4.1M) | (14.2M) | 63.5M | (9.5M) | (8.6M) | (8.1M) | |
Retained Earnings Total Equity | 16.5B | 14.0B | 13.9B | 16.5B | 18.9B | 11.5B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.MSFT | Microsoft | |
GM | General Motors | |
CRM | Salesforce |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biogen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Complementary Tools for Biogen Stock analysis
When running Biogen's price analysis, check to measure Biogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biogen is operating at the current time. Most of Biogen's value examination focuses on studying past and present price action to predict the probability of Biogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biogen's price. Additionally, you may evaluate how the addition of Biogen to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |
Is Biogen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biogen. If investors know Biogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.011 | Earnings Share 8 | Revenue Per Share 66.688 | Quarterly Revenue Growth (0.07) | Return On Assets 0.0486 |
The market value of Biogen Inc is measured differently than its book value, which is the value of Biogen that is recorded on the company's balance sheet. Investors also form their own opinion of Biogen's value that differs from its market value or its book value, called intrinsic value, which is Biogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biogen's market value can be influenced by many factors that don't directly affect Biogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.